Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 316

1.

Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.

Kiess AP, Damast S, Makker V, Kollmeier MA, Gardner GJ, Aghajanian C, Abu-Rustum NR, Barakat RR, Alektiar KM.

Gynecol Oncol. 2012 Nov;127(2):321-5. doi: 10.1016/j.ygyno.2012.07.112. Epub 2012 Jul 28.

PMID:
22850412
2.

Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy.

Desai NB, Kiess AP, Kollmeier MA, Abu-Rustum NR, Makker V, Barakat RR, Alektiar KM.

Gynecol Oncol. 2013 Dec;131(3):604-8. doi: 10.1016/j.ygyno.2013.09.019. Epub 2013 Sep 20.

PMID:
24055615
3.

Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.

Turner BC, Knisely JP, Kacinski BM, Haffty BG, Gumbs AA, Roberts KB, Frank AH, Peschel RE, Rutherford TJ, Edraki B, Kohorn EI, Chambers SK, Schwartz PE, Wilson LD.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):77-84.

PMID:
9422561
4.

Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.

Sood BM, Jones J, Gupta S, Khabele D, Guha C, Runowicz C, Goldberg G, Fields A, Anderson P, Vikram B.

Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):208-16.

PMID:
12909235
5.

Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer.

Alektiar KM, Makker V, Abu-Rustum NR, Soslow RA, Chi DS, Barakat RR, Aghajanian CA.

Gynecol Oncol. 2009 Jan;112(1):142-5. doi: 10.1016/j.ygyno.2008.10.006. Epub 2008 Nov 20.

6.

Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).

Goldberg H, Miller RC, Abdah-Bortnyak R, Steiner M, Yildiz F, Meirovitz A, VillĂ  S, Poortmans PM, Azria D, Zidan J, Ozsahin M, Abacioglu U, Gold DG, Amit A, Lavie O, Atahan IL, Kuten A; Rare Cancer Network.

Gynecol Oncol. 2008 Feb;108(2):298-305. Epub 2007 Dec 21.

PMID:
18096209
7.

A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium.

Jhingran A, Ramondetta LM, Bodurka DC, Slomovitz BM, Brown J, Levy LB, Garcia ME, Eifel PJ, Lu KH, Burke TW.

Gynecol Oncol. 2013 May;129(2):304-9. doi: 10.1016/j.ygyno.2013.01.025. Epub 2013 Feb 4.

8.

Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC).

Fields AL, Einstein MH, Novetsky AP, Gebb J, Goldberg GL.

Gynecol Oncol. 2008 Jan;108(1):201-6. Epub 2007 Nov 8.

PMID:
17997145
9.

The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.

Barney BM, Petersen IA, Mariani A, Dowdy SC, Bakkum-Gamez JN, Haddock MG.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):109-15. doi: 10.1016/j.ijrobp.2012.03.011. Epub 2012 Apr 28.

PMID:
22543202
10.

Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer.

Milgrom SA, Kollmeier MA, Abu-Rustum NR, Tew WP, Sonoda Y, Barakat RR, Alektiar KM.

Gynecol Oncol. 2013 Sep;130(3):436-40. doi: 10.1016/j.ygyno.2013.06.024. Epub 2013 Jun 22.

PMID:
23800696
11.

Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy.

Mehta N, Yamada SD, Rotmensch J, Mundt AJ.

Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):1004-9.

PMID:
14575831
12.

Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study.

Gadducci A, Cosio S, Landoni F, Maggino T, Zola P, Fuso L, Sartori E.

Int J Gynecol Cancer. 2012 Oct;22(8):1355-60.

PMID:
22976496
13.

Evaluation of adjuvant therapy in women with uterine papillary serous cancer.

Al Husaini H, Soudy H, Darwish A, Ahmed M, Eltigani A, Edesa W, Abdelsalam M.

Ann Saudi Med. 2012 Jan-Feb;32(1):27-31.

PMID:
22156636
14.

Uterine papillary serous carcinoma: patterns of failure and survival.

Wang W, DO V, Hogg R, Wain G, Brand A, Bull C, Stenlake A, Gebski V.

Aust N Z J Obstet Gynaecol. 2009 Aug;49(4):419-25. doi: 10.1111/j.1479-828X.2009.01016.x.

PMID:
19694700
15.

Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer.

Townamchai K, Berkowitz R, Bhagwat M, Damato AL, Friesen S, Lee LJ, Matulonis U, O'Farrell D, Viswanathan AN.

Gynecol Oncol. 2013 Apr;129(1):18-21. doi: 10.1016/j.ygyno.2012.12.026. Epub 2012 Dec 21.

PMID:
23262378
16.

Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristics.

Young MR, Higgins SA, Ratner E, Yu JB, Mani S, Silasi DA, Azodi M, Rutherford T, Schwartz PE, Damast S.

Int J Gynecol Cancer. 2015 Mar;25(3):431-9. doi: 10.1097/IGC.0000000000000376.

PMID:
25621409
17.

Phase II trial of adjuvant pelvic radiation "sandwiched" between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma.

Einstein MH, Frimer M, Kuo DY, Reimers LL, Mehta K, Mutyala S, Huang GS, Hou JY, Goldberg GL.

Gynecol Oncol. 2012 Jan;124(1):21-5. doi: 10.1016/j.ygyno.2011.10.007. Epub 2011 Oct 27.

18.

Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma.

Mundt AJ, Murphy KT, Rotmensch J, Waggoner SE, Yamada SD, Connell PP.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1154-60.

PMID:
11483324
19.

Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma.

Low JS, Wong EH, Tan HS, Yap SP, Chua EJ, Sethi VK, Soh LT, Low J, Tay EH, Chew SH.

Gynecol Oncol. 2005 Apr;97(1):171-7.

PMID:
15790454
20.

Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.

Kelly MG, O'Malley D, Hui P, McAlpine J, Dziura J, Rutherford TJ, Azodi M, Chambers SK, Schwartz PE.

Gynecol Oncol. 2004 Dec;95(3):469-73.

PMID:
15581948
Items per page

Supplemental Content

Write to the Help Desk